Results 1 to 10 of about 118,074 (301)

Invasive fungal infections

African Journal of Thoracic and Critical Care Medicine, 2022
-
S Kwarteng Owusu
doaj   +3 more sources

Invasive Fungal Infections 2021

Journal of Fungi, 2022
Invasive fungal infections (IFIs) represent a significant problem in a large proportion of immunocompromised individuals and critically ill patients [...]
Immaculata Xess, Livio Pagano, Yubhisha Dabas   +2 more
doaj   +3 more sources

Invasive fungal infections and the management in immunocompromised conditions [PDF]

Journal of Family Medicine and Primary Care
Invasive fungal infections, being opportunistic, lead to severe disease in immunocompromised hosts with an increase in morbidity and mortality. The most common causative agents include Candida, Mucorales, Aspergillus, Cryptococcus, and Pneumocystis ...
Garima Anandani, Mayuri Bhise, Ashwini Agarwal   +2 more
doaj   +2 more sources

Posaconazole in the management of refractory invasive fungal infections [PDF]

Therapeutics and Clinical Risk Management, 2008
Stefan Langner, Philipp B Staber, Peter NeumeisterDivision of Hematology, Department of Internal Medicine, Medical University of Graz, AustriaAbstract: The rising incidence of invasive fungal infections due to the expanding population of ...
Stefan Langner, Philipp B Staber, Peter Neumeister   +2 more
doaj   +3 more sources

Eye Infections Caused by Filamentous Fungi: Spectrum and Antifungal Susceptibility of the Prevailing Agents in Germany

Journal of Fungi, 2021
Fungal eye infections can lead to loss of vision and blindness. The disease is most prevalent in the tropics, although case numbers in moderate climates are increasing as well.
Grit Walther, Anna Zimmermann, Johanna Theuersbacher, Kerstin Kaerger, Marie von Lilienfeld-Toal, Mathias Roth, Daniel Kampik, Gerd Geerling, Oliver Kurzai   +8 more
doaj   +1 more source

Animal Histoplasmosis in Europe: Review of the Literature and Molecular Typing of the Etiological Agents

Journal of Fungi, 2022
Histoplasmosis has been previously diagnosed in animals from Europe. The aim of this study is to review the literature on these reports, to analyze cases diagnosed at our laboratory (2000–2022) and to improve molecular typing of Histoplasma capsulatum ...
Dunja Wilmes, Ursula Mayer, Peter Wohlsein, Michael Suntz, Jasmin Gerkrath, Christoph Schulze, Ina Holst, Wolf von Bomhard, Volker Rickerts   +8 more
doaj   +1 more source

Aspergillus-Derived Galactosaminogalactan Triggers Complement Activation on Human Platelets

Frontiers in Immunology, 2020
Invasive fungal infections caused by Aspergillus (A.) and Mucorales species still represent life-threatening diseases in immunocompromised individuals, and deeper knowledge about fungal interactions with elements of innate immunity, such as complement ...
Hemalata Deshmukh, Cornelia Speth, Cornelia Speth, Donald C. Sheppard, Magdalena Neurauter, Reinhard Würzner, Cornelia Lass-Flörl, Cornelia Lass-Flörl, Günter Rambach, Günter Rambach   +9 more
doaj   +1 more source

Detection of Histoplasma DNA from Tissue Blocks by a Specific and a Broad-Range Real-Time PCR: Tools to Elucidate the Epidemiology of Histoplasmosis

Journal of Fungi, 2020
Lack of sensitive diagnostic tests impairs the understanding of the epidemiology of histoplasmosis, a disease whose burden is estimated to be largely underrated.
Dunja Wilmes, Ilka McCormick-Smith, Charlotte Lempp, Ursula Mayer, Arik Bernard Schulze, Dirk Theegarten, Sylvia Hartmann, Volker Rickerts   +7 more
doaj   +1 more source

Invasive and Subcutaneous Infections Caused by Filamentous Fungi: Report from a Portuguese Multicentric Surveillance Program

Microorganisms, 2022
Invasive fungal infections (IFI) have significantly increased over the past years due to advances in medical care for the at-risk immunocompromised population.
Cristina Veríssimo, Cristina Toscano, Teresa Ferreira, Gabriela Abreu, Helena Simões, José Diogo, Dinah Carvalho, Felicidade Santiago, Ana Lima, Ana Maria Queirós, Raquel Sabino   +10 more
doaj   +1 more source

Comparison of fluconazole and posaconazole for fungal prophylaxis in high- risk patients with hematological malignity [PDF]

Journal of Microbiology and Infectious Diseases, 2014
Objective: To compare the frequency of fungal infection and mortality rates in patients with hematological malignity and receiving either flucanazole (FLU) or posaconazole (POS) prophylaxis. Methods: This retrospective, observational study investigated
Selçuk Kaya, Mehmet Sönmez , İftihar Köksal , Eda Gençalioğlu , Mustafa Yılmaz , Gürdal Yılmaz   +5 more
doaj   +1 more source